When considering the expression of two genes, ATP11B and PTDSS2, simultaneous low ATP11B expression and higher PTDSS2 expression are associated with worse prognoses compared to patients with higher ATP11B and lower PTDSS2 expression in the tumor [98]. Here, ATP11B is linked to neoplasm.